Squarepoint Ops LLC Harpoon Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $83,660 - $115,124	-14,703 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.88 - $14.0 $115,859 - $205,842	14,703 New	14,703 $116,000
Q1 2021 May 17, 2021	SELL	$17.65 - $24.16 $305,556 - $418,257	-17,312 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.83 - $17.84 $51 - $71	4 Added 0.02%	17,312 $288,000
Q3 2020 Nov 16, 2020	SELL	$11.01 - $18.52 $234,667 - $394,735	-21,314 Reduced 55.19%	17,308 $294,000
Q2 2020 Aug 14, 2020	SELL	$11.11 - $24.72 $322,278 - $717,077	-29,008 Reduced 42.89%	38,622 $641,000
Q1 2020 May 15, 2020	BUY	$10.74 - $16.32 $368,500 - $559,955	34,311 Added 102.98%	67,630 $783,000
Q4 2019 Feb 14, 2020	BUY	$12.94 - $20.58 $431,147 - $685,705	33,319 New	33,319 $493,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.